[EAU guidelines for prostate cancer: to screen or not to screen?].
作者信息
Baumann C, Behbahani T E
出版信息
Actas Urol Esp. 2012 Jan;36(1):1. doi: 10.1016/j.acuro.2011.07.017. Epub 2011 Oct 19.
PMID:22014388
Abstract
摘要
相似文献
1
[EAU guidelines for prostate cancer: to screen or not to screen?].
Actas Urol Esp. 2012 Jan;36(1):1. doi: 10.1016/j.acuro.2011.07.017. Epub 2011 Oct 19.
2
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma.
Eur Urol. 2004 Aug;46(2):147-54. doi: 10.1016/j.eururo.2004.04.011.
3
[Urothelial tumors].
Prog Urol. 2004 Nov;14(4 Suppl 1):957, 959-96.
4
[Urothelial carcinoma].
Urologe A. 2001 Nov;40(6):441. doi: 10.1007/s001200170001.
5
Transitional cell carcinoma of the pelvicalices and ureter.
AJR Am J Roentgenol. 1990 Oct;155(4):713-22. doi: 10.2214/ajr.155.4.2119098.
6
Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes.
Urology. 2011 Jul;78(1):87-92. doi: 10.1016/j.urology.2011.03.032. Epub 2011 May 23.
7
Contemporary Evaluation and Management of Upper Tract Urothelial Cancer.
Urology. 2016 Aug;94:17-23. doi: 10.1016/j.urology.2015.12.035. Epub 2016 Feb 2.
8
[A case of synchronous ipsilateral renal cell carcinoma and ureteral transitional cell carcinoma].
Hinyokika Kiyo. 2000 Feb;46(2):113-6.
9
[European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
Actas Urol Esp. 2012 Jan;36(1):2-14. doi: 10.1016/j.acuro.2011.09.001. Epub 2011 Oct 29.
10
Diagnosis and management of upper tract urothelial carcinoma.
Minerva Urol Nefrol. 2014 Mar;66(1):37-48.
引用本文的文献
1
The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.
Oncogene. 2015 Sep 3;34(36):4735-45. doi: 10.1038/onc.2014.401. Epub 2014 Dec 15.
Zotero 插件